Research from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.

A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.

A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer.

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.

A pediatric cancer patient received new 3D metallic ribs from Spain to help treat and manage her disease.

Physicians, nurse practitioners, social workers, spiritual care professionals, clinical pharmacists and other specialized providers all work together to create a unified palliative care team at Michigan Medicine.

An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.

After an awake surgery to remove a cancerous brain tumor, a Michigan man is living “more deliberately” than ever — officiating a high school wrestling state championship and participating in research for a potential cure.

Research, led by Michigan Medicine and the University of Michigan, suggests that glioblastoma cells are poised near a “critical point” of order and disorder — meaning, the cells possess some form of large-scale coordination throughout the whole tumor that allows them to respond in practical unison to attempts to kill tumor cells, such as chemotherapy or radiation.

The National Cancer Institute has awarded the U-M Rogel Cancer Center a grant worth $37 million over five years and renewed the center’s designation as a “comprehensive cancer center.”

Research finds genetic testing for cancer can bring more knowledge to patients and their relatives, but not many people get it done.

Sugar free: investigator finds cancer cells use a new fuel in absence of sugar

To combat critical drug shortages, a Michigan Medicine physician advocates for better solutions to the ongoing supply chain issues regarding medications in the United States.

A team of Michigan Medicine researchers have identified a mechanism in mice for how obesity affects some oral cancers’ ability to escape from the immune system.

For thyroid cancer, experts examine the current state of overdiagnosis, new therapies, health equity concerns and more.